PRHSX vs. FIJYX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Advisor Biotechnology Fund Class Z (FIJYX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. FIJYX is managed by Fidelity. It was launched on Oct 2, 2018.
Performance
PRHSX vs. FIJYX - Performance Comparison
Loading graphics...
PRHSX vs. FIJYX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | -6.24% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | -12.28% |
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 2.35% | 40.09% | 0.03% | 11.19% | -7.60% | -2.76% | 32.72% | 26.25% | -11.45% |
Returns By Period
In the year-to-date period, PRHSX achieves a -6.24% return, which is significantly lower than FIJYX's 2.35% return.
PRHSX
- 1D
- 3.78%
- 1M
- -4.81%
- YTD
- -6.24%
- 6M
- 20.54%
- 1Y
- 27.86%
- 3Y*
- 10.42%
- 5Y*
- 5.52%
- 10Y*
- 11.84%
FIJYX
- 1D
- 5.06%
- 1M
- -0.73%
- YTD
- 2.35%
- 6M
- 15.76%
- 1Y
- 55.98%
- 3Y*
- 18.69%
- 5Y*
- 8.12%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. FIJYX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is higher than FIJYX's 0.61% expense ratio.
Return for Risk
PRHSX vs. FIJYX — Risk / Return Rank
PRHSX
FIJYX
PRHSX vs. FIJYX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Advisor Biotechnology Fund Class Z (FIJYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRHSX | FIJYX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.13 | 1.96 | -0.83 |
Sortino ratioReturn per unit of downside risk | 1.93 | 2.56 | -0.63 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.33 | -0.08 |
Calmar ratioReturn relative to maximum drawdown | 1.94 | 3.20 | -1.25 |
Martin ratioReturn relative to average drawdown | 5.86 | 12.85 | -6.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRHSX | FIJYX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.13 | 1.96 | -0.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.35 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.60 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.43 | +0.21 |
Correlation
The correlation between PRHSX and FIJYX is 0.84, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PRHSX vs. FIJYX - Dividend Comparison
PRHSX's dividend yield for the trailing twelve months is around 25.66%, more than FIJYX's 1.41% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 25.66% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 1.41% | 1.44% | 0.00% | 1.55% | 0.00% | 18.90% | 8.13% | 6.49% | 2.35% | 0.00% | 0.00% | 0.00% |
Drawdowns
PRHSX vs. FIJYX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -42.96%, which is greater than FIJYX's maximum drawdown of -38.53%. Use the drawdown chart below to compare losses from any high point for PRHSX and FIJYX.
Loading graphics...
Drawdown Indicators
| PRHSX | FIJYX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -38.53% | -4.43% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -13.59% | +0.78% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -36.39% | +8.78% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | — | — |
Current DrawdownCurrent decline from peak | -9.18% | -2.49% | -6.69% |
Average DrawdownAverage peak-to-trough decline | -8.75% | -11.76% | +3.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.24% | 3.69% | +0.55% |
Volatility
PRHSX vs. FIJYX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund (PRHSX) is 6.68%, while Fidelity Advisor Biotechnology Fund Class Z (FIJYX) has a volatility of 9.34%. This indicates that PRHSX experiences smaller price fluctuations and is considered to be less risky than FIJYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRHSX | FIJYX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.68% | 9.34% | -2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 16.36% | 17.01% | -0.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.59% | 26.00% | -3.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.07% | 23.43% | -5.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.68% | 25.07% | -5.39% |